These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

636 related items for PubMed ID: 12390825

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Efficacy, safety and potential clinical roles of the COX-2-specific inhibitors.
    van der Bijl P, van der Bijl P.
    Int J Immunopathol Pharmacol; 2003; 16(2 Suppl):17-22. PubMed ID: 14552700
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [The cardiovascular safety of cyclooxygenase-2 (COX-2) inhibitors].
    Hasdai D, Gottlieb S, Godbourt U, Hod H, Kaluski E.
    Harefuah; 2002 Oct; 141(10):922-4. PubMed ID: 12420602
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. COX-2 inhibitors. What is their place?
    McGettigan P.
    Aust Fam Physician; 2000 Sep; 29(9):847-52. PubMed ID: 11008387
    [Abstract] [Full Text] [Related]

  • 10. Forthcoming non-steroidal anti-inflammatory drugs: are they really devoid of side effects?
    Bjarnason I.
    Ital J Gastroenterol Hepatol; 1999 Sep; 31 Suppl 1():S27-36. PubMed ID: 10379467
    [Abstract] [Full Text] [Related]

  • 11. [Selective COX-2 non-steroidal anti-inflammatory agents and gastrointestinal toxicity].
    Zaragoza A, Llorente MJ, García MM, Ramírez JJ, Lloret G, Machancoses A.
    Rev Esp Enferm Dig; 2001 Dec; 93(12):819-20. PubMed ID: 11995364
    [No Abstract] [Full Text] [Related]

  • 12. [Non-steroidal anti-inflammatory drugs and cyclooxygenase-2 selectivity in gastroenterology].
    Ledro Cano D, Gómez Rodríguez BJ, Torres Domínguez Y, Hergueta Delgado P, Herrerías Esteban JM, Herrerías Gutiérrez JM.
    Rev Esp Enferm Dig; 1999 Apr; 91(4):305-9. PubMed ID: 10348929
    [Abstract] [Full Text] [Related]

  • 13. [The use of non-steroidal anti inflammatory drugs (NSAIDs)--COX-2 inhibitors].
    Tishler M, Langevetiz P, Nesher G.
    Harefuah; 2002 Oct; 141(10):920-1. PubMed ID: 12420601
    [No Abstract] [Full Text] [Related]

  • 14. [COX-2 inhibitor to whom?].
    Martio J.
    Duodecim; 2000 Oct; 116(12):1265-7. PubMed ID: 11988961
    [No Abstract] [Full Text] [Related]

  • 15. [Clinical pharmacology of selective inhibitors of cyclooxygenase-2].
    Patrignani P.
    Acta Otorhinolaryngol Ital; 2003 Aug; 23(4 Suppl 74):13-8, 37-40. PubMed ID: 15058604
    [No Abstract] [Full Text] [Related]

  • 16. [Specific inhibitors of cyclooxygenase type 2] ].
    Tomasová-Studýnková J.
    Vnitr Lek; 2002 May; 48(5):403-8. PubMed ID: 12061207
    [Abstract] [Full Text] [Related]

  • 17. COX-2-selective inhibitors (COXIBs): gastrointestinal safety.
    Pronai L, Hritz I, Molnar B, Herszenyi L, Tulassay Z.
    Int J Immunopathol Pharmacol; 2003 May; 16(2 Suppl):23-30. PubMed ID: 14552701
    [Abstract] [Full Text] [Related]

  • 18. [Adverse effect-free analgesia. New COX-2 inhibitor is even more selective].
    MMW Fortschr Med; 2003 May 01; 145(18):54. PubMed ID: 12808824
    [No Abstract] [Full Text] [Related]

  • 19. [Biological functions of cyclooxygenase 2: control of its expression and activity].
    Jacquemin C.
    J Soc Biol; 2000 May 01; 194(3-4):189-93. PubMed ID: 11324321
    [Abstract] [Full Text] [Related]

  • 20. [Arthrosis drugs critically evaluated. Emphasis on cartilage protection].
    Wepner U.
    MMW Fortschr Med; 2002 Mar 28; 144(13):4-8. PubMed ID: 12001589
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.